Dave Mazza is the Head of Product at Direxion. In this interview, Dave discusses the details of Leveraged and Inverse ETFs, use cases, and educational references available to potential investors. Dave also discusses the recent launch of the Direxion mRNA ETF (Ticker: MSGR) and the outlook for future uses of mRNA technology. Rss
